AstraZeneca Announces ‘Highly Effective’ COVID-19 Vaccine

AstraZeneca said early Monday that clinical trials of its COVID-19 vaccine in Britain and Brazil have shown it is “highly effective in preventing COVID-19″ without  “hospitalizations or severe cases of the disease” in any of the trial’s volunteers. The England-based pharmaceutical company tested two dosing regimens.  One regimen had an efficacy rate of 90%.  The second regimen has an average efficacy of 70%.  “More data will…

read more

COVID Nurse: ‘Many of us Have PTSD’ 

Almost 1,400 frontline healthcare workers in the U.S. have apparently died of COVID-19, according to a joint investigation by British newspaper, The Guardian, and Kaiser Health News.  One-third of the dead health care workers were nurses, the study said.Many of the health care workers, the report said, “are struggling with illness, trauma and exhaustion.” FILE –…

read more

Trump Makes Late-term Bid to Lower Prescription Drug Costs

Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs.But in a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether President-elect Joe Biden’s administration will accept, amend…

read more

Partners Pfizer, BioNTech Seek Emergency Vaccine Authorization From FDA

Pharmaceutical company Pfizer and its German partner, BioNTech, said Friday they have filed for emergency authorization from the U.S. Food and Drug Administration (FDA) to use their COVID-19 vaccine, saying they are poised to begin distribution within hours after authorization. The application comes after the companies said testing shows the vaccine has an effectiveness rate of…

read more